Kesimpta and Ocrevus are both used to treat certain forms of MS, but they differ in administration and specific indications. Kesimpta is a subcutaneous injection, while Ocrevus is given as an intravenous infusion. Some studies suggest Kesimpta may offer more convenience due to its at-home administration, but direct clinical comparisons are limited. Patients should discuss with their doctors to determine the best option based on their specific condition and lifestyle.
Alert: Order your 3-month supply by October 12 to help avoid potential customs delays.
Get Semaglutide for $184 or Ozempic for $329
